WuXi Biologics (Cayman) Inc
OTC:WXXWY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
OTC:WXXWY
|
CN |
|
U
|
Unjha Formulations Ltd
BSE:531762
|
IN |
|
Laurentian Bank of Canada
TSX:LB
|
CA |
|
A
|
Admicom Oyj
OMXH:ADMCM
|
FI |
|
Sumber Tani Agung Resources Tbk PT
IDX:STAA
|
ID |
|
E
|
EITA Resources Bhd
KLSE:EITA
|
MY |
|
Cogobuy Group
HKEX:400
|
CN |
|
Cyberloq Technologies Inc
OTC:CLOQ
|
US |
|
Dongfeng Motor Group Co Ltd
HKEX:489
|
CN |
|
Tokyu Fudosan Holdings Corp
TSE:3289
|
JP |
|
S
|
Sakura KCS Corp
TSE:4761
|
JP |
|
Inocycle Technology Group Tbk PT
IDX:INOV
|
ID |
|
C
|
China Kings Resources Group Co Ltd
SSE:603505
|
CN |
|
Miroku Jyoho Service Co Ltd
TSE:9928
|
JP |
|
Thungela Resources Ltd
OTC:TNGRF
|
ZA |
|
Itafos Inc
F:82E
|
US |
|
T
|
Taesung Co Ltd
KOSDAQ:323280
|
KR |
|
Crawford United Corp
OTC:CRAWA
|
US |
|
E
|
EnterSoft SA
ATHEX:ENTER
|
GR |
|
A
|
Alphalogic Industries Ltd
BSE:543937
|
IN |
|
Ocean Plastics Co Ltd
TWSE:1321
|
TW |
|
American Bio Medica Corp
OTC:ABMC
|
US |
|
A
|
Allianz Saudi Fransi Cooperative Insurance Company SJSC
SAU:8040
|
SA |
|
COFCO Biotechnology Co Ltd
SZSE:000930
|
CN |
Wall Street
Price Targets
WXXWY Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for
WXXWY
is 11.2 USD
with a low forecast of 7.63 USD and a high forecast of 14.34 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is WXXWY's stock price target?
Price Target
11.2
USD
According to Wall Street analysts, the average 1-year price target for
WXXWY
is 11.2 USD
with a low forecast of 7.63 USD and a high forecast of 14.34 USD.
What is WuXi Biologics (Cayman) Inc's Revenue forecast?
Projected CAGR
17%
For the last 9 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's revenue is
48%.
The projected
CAGR
for the next 4 years is
17%.
What is WuXi Biologics (Cayman) Inc's Operating Income forecast?
Projected CAGR
22%
For the last 9 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's operating income is
62%.
The projected
CAGR
for the next 4 years is
22%.
What is WuXi Biologics (Cayman) Inc's Net Income forecast?
Projected CAGR
24%
For the last 9 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's net income is
62%.
The projected
CAGR
for the next 4 years is
24%.
